Home › Therapeutic areas › Oncology › Waldenstrom's Macroglobulinemia
Waldenstrom's Macroglobulinemia (2 companies)
Companies with an active program in Waldenstrom's Macroglobulinemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences | Oncology | 1 | Approved | 11 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 2 | Phase 2 | 15 |
No companies match.